Companies / BOC Sciences / Ustekinumab
BOC Sciences

Ustekinumab | BOC Sciences

Ustekinumab is a human monoclonal antibody approved for the treatment of psoriasis and Crohn's disease. Ustekinumab acts via blocking IL-12 and IL-23.

Reviews


No reviews yet

ABOUT THE COMPANY

BOC Sciences specializes in small molecule synthesis, biosynthesis, purification, and characterization. It provides a wide range of research chemicals and biochemicals, including inhibitors, building blocks, carbohydrates, nucleosides, nucleotides, GMP Products, impurities and metabolites, APIs, natural compounds, ADCs, stem cell molecules and chiral compounds.